A group of researchers at The University of Texas Health Science Center at San Antonio have developed a way to deliver nanoparticle radiation directly to the brain tumor and keep it there. The method doses the tumor itself with much higher levels of radiation 20 to 30 times the current dose of radiation therapy to patients but spares a much greater area of brain tissue. Our speaker is Andrew Brenner, M.D., Ph.D., of the Cancer Therapy & Research Center (CTRC) at the UT Health Science Center. Join us and learn about Clinical Trials at the CTRC at TPR's event.
Andrew Brenner, M.D., Ph.D., of the Cancer Therapy & Research Center (CTRC) at the UT Health Science Center, is a specialist in both breast cancer and malignancies of the brain and spinal cord. Dr. Brenner focuses not only on clinical management but also on the development of novel therapies to treat these cancers. At the CTRC he is extensively involved in clinical trials that make new treatments available to South Texas patients. This included a first-in-man study of a new radiation treatment implanted in the center of a patient's brain tumor called a glioblastoma. Dr. Brenner earned his bachelor's degree in biochemistry at Texas A&M University and went on to earn his doctorate in biological science and tumor biology at The University of Texas M.D. Anderson Cancer Center - Science Park. Dr. Brenner received his medical degree from the Texas Tech University Health Sciences Center and completed a residency in internal medicine at Scott and White Hospital in Lubbock. He completed his fellowship in hematology and medical oncology at the UT Health Science Center.